Literature DB >> 21418205

Of mice and men: experimental autoimmune encephalitis and multiple sclerosis.

Adam E Handel1, Matthew R Lincoln, Sreeram V Ramagopalan.   

Abstract

BACKGROUND: Research using experimental autoimmune encephalitis (EAE) models accounts for almost 20% of the papers. published in multiple sclerosis (MS).
METHODS: We performed a literature review of papers indexed with ISI Web of Science on EAE and MS over the last 30 years and a detailed analysis of studies of molecular pathways in EAE published in 2008 and 2009.
RESULTS: The impact of EAE studies declines more rapidly than other studies published on MS (EAE cited corrected half-life = 4·00 years vs. MS cited corrected half-life = 9·66 years, P < 0·0001). The pathology of EAE differs quite markedly from that observed in the human disease. EAE has implicated many different genes as important to pathogenesis but only a minority of these are supported by human studies.
CONCLUSIONS: Future research should critically appraise precisely what is being modelled by EAE before drawing conclusions about human disease.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Year:  2011        PMID: 21418205     DOI: 10.1111/j.1365-2362.2011.02519.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  17 in total

1.  Immunomodulatory effects of Trichinella spiralis-derived excretory-secretory antigens.

Authors:  Ivana Radovic; Alisa Gruden-Movsesijan; Natasa Ilic; Jelena Cvetkovic; Slavko Mojsilovic; Marija Devic; Ljiljana Sofronic-Milosavljevic
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 2.  Of Mice, Dirty Mice, and Men: Using Mice To Understand Human Immunology.

Authors:  David Masopust; Christine P Sivula; Stephen C Jameson
Journal:  J Immunol       Date:  2017-07-15       Impact factor: 5.422

3.  Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.

Authors:  Assia Shisheva; Diego Sbrissa; Bo Hu; Jun Li
Journal:  Mol Neurobiol       Date:  2019-07-16       Impact factor: 5.590

Review 4.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

5.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 6.  Immunotherapy advances for glioblastoma.

Authors:  David A Reardon; Gordon Freeman; Catherine Wu; E Antonio Chiocca; Kai W Wucherpfennig; Patrick Y Wen; Edward F Fritsch; William T Curry; John H Sampson; Glenn Dranoff
Journal:  Neuro Oncol       Date:  2014-09-04       Impact factor: 12.300

Review 7.  The evidence for a role of B cells in multiple sclerosis.

Authors:  G Disanto; J M Morahan; M H Barnett; G Giovannoni; S V Ramagopalan
Journal:  Neurology       Date:  2012-03-13       Impact factor: 9.910

Review 8.  Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?

Authors:  Jorge Correale; Mauricio F Farez
Journal:  Front Cell Infect Microbiol       Date:  2012-08-24       Impact factor: 5.293

9.  Abandon the mouse research ship? Not just yet!

Authors:  Marcin F Osuchowski; Daniel G Remick; James A Lederer; Charles H Lang; Ansgar O Aasen; Mayuki Aibiki; Luciano C Azevedo; Soheyl Bahrami; Mihaly Boros; Robert Cooney; Salvatore Cuzzocrea; Yong Jiang; Wolfgang G Junger; Hiroyuki Hirasawa; Richard S Hotchkiss; Xiang-An Li; Peter Radermacher; Heinz Redl; Reinaldo Salomao; Amin Soebandrio; Christoph Thiemermann; Jean-Louis Vincent; Peter Ward; Yong-Ming Yao; Huang-Ping Yu; Basilia Zingarelli; Irshad H Chaudry
Journal:  Shock       Date:  2014-06       Impact factor: 3.533

10.  Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.

Authors:  Suzanne Doolen; Tommaso Iannitti; Renee R Donahue; Benjamin C Shaw; Carolyn M Grachen; Bradley K Taylor
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.